Vizorifa 400 Tablet
Marketer
Ventus Pharmaceuticals Pvt Ltd
Salt Composition
Rifaximin (400mg)
Overview Vizorifa 400 Tablet
Hepatic encephalopathy, a liver-related condition causing toxin buildup and brain impairment, and infectious diarrhea are treated by the antibiotic Vizorifa 400mg tablets. This medication combats intestinal bacteria, inhibiting their growth and eliminating them. It's administered alone or concurrently with other drugs, with or without food, ideally at the same time daily, following the prescribed dosage and duration. Consistent daily intake maximizes efficacy; premature discontinuation can cause infection recurrence and treatment complications. Potential side effects—vomiting, headache, dizziness, nausea, rashes, arthralgia, and depression—are usually transient, resolving with continued use. Persistent or bothersome side effects warrant medical attention. A harmless, temporary reddish urine discoloration may occur. Prior to commencing treatment, inform your physician about pregnancy, breastfeeding, liver, kidney, or heart conditions, and any drug allergies.
Primary Ingredients of Vizorifa 400 Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Vizorifa 400 Tablet
Managing hepatic encephalopathy and infectious diarrhea.
Major Benefits of Vizorifa 400 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Vizorifa 400 Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Vizorifa 400 Tablet:
- Dizziness
- Nausea
- Peripheral edema
- Ascites (accumulation of fluid in the abdominal cavity)
- Fatigue
- Depression
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Joint pain
- Rash
- Muscle pain
How to use Vizorifa 400 Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vizorifa 400 Tablets can be consumed with or without food, although consistent timing is recommended.
How Vizorifa 400 Tablet works:
Vizorifa 400mg tablets contain an antibiotic that combats ammonia-producing bacteria within the gastrointestinal system. This action addresses the underlying infection and alleviates hepatic encephalopathy symptoms such as restlessness, cognitive impairment, and myopathy. Furthermore, it contributes to a lower frequency of future hepatic encephalopathy occurrences.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Vizorifa 400 Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Vizorifa 400 Tablet during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Lactation and the use of Vizorifa 400 Tablets appear compatible. Available human data indicates minimal infant risk associated with the medication.
DrivingSAFE
Driving ability is typically unaffected by Vizorifa 400 Tablet.
KidneySAFE IF PRESCRIBED
The use of Vizorifa 400 Tablet in individuals with kidney impairment is likely safe. Preliminary findings indicate dose modification may be unnecessary; however, physician consultation is recommended.
LiverCAUTION
Patients with severe hepatic impairment should use Vizorifa 400 mg tablets cautiously. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Vizorifa 400 Tablet :
Should you forget a Vizorifa 400 Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vizorifa 400 Tablet
| Label | Value |
|---|---|
| Chemical Category | Rifamycin-based compounds |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Active Class | Rifamycin Antibiotics: RNA Polymerase Inhibitors |
3,018 People bought this recently